Clinical landscape of therapeutic vaccines for ovarian cancer: current status, challenges, and future directions
The observed heterogeneity in immune-response reporting further highlights the need for prespecified, harmonized, and vaccine-specific immune monitoring frameworks in future vaccine trials, as well as the need for large-scale multicenter randomized Phase II/III trials to facilitate the translation of vaccine-induced im...